Published Date: 26 Apr 2023
According to recent studies, the prevalence of HIV is 2.5 times higher in South London's mental health service users than it is in the general population. The article was released today in BMJ Open.
Read Full NewsIn honor of Veterans Day, Clayton Mucha, DO, neurorehabilitation physiatrist at Burke Rehabilitation in New York, discusses the lasting effects of traumatic brain injury in military personnel.
GV101 receives FDA fast track designation for the treatment of Friedreich ataxia, with a phase 2 trial planned to begin enrollment in late 2026.
The FDA granted fast track designation to FRP-003, an investigational oral botanical drug candidate for Long COVID, ahead of a planned phase 2 trial evaluating fatigue in approximately 220 adults.
At a NeurologyLive Clinical Forum in Phoenix, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how a lack of adult neuro-oncology infrastructure is shaping how NF1-associated plexiform neurofibromas get recognized, referred, and treated.
Robert Bermel, MD, discusses advances in disease-modifying therapies, the challenges of monitoring MS progression, and emerging biomarkers and treatments that may address remaining unmet needs.
Q&A: Healthy Skin Month—What Clinicians Should Watch in Skin Cancer Care
1.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
2.
DNA origami offers more accurate imaging in the fight against pancreatic cancer
3.
Modified personalized cancer vaccine generates powerful immune response
4.
Advanced breast cancer patients living longer thanks to improvements in treatment and care
5.
Weight loss trial reports success for breast cancer patients at one year mark
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
3.
Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances
4.
Pathophysiology of Cellular Iron Redistribution During Chronic Inflammation
5.
Unlocking the Potential of Polatuzumab for Cancer Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
2.
Cancer Care: From Awareness to Recovery
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
Recognizing General Warning Signs of Cancer
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation